Literature DB >> 11585455

Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.

M Tercel1, A E Lee, A Hogg, R F Anderson, H H Lee, B G Siim, W A Denny, W R Wilson.   

Abstract

Nitrobenzyl quaternary salts of nitrogen mustards have been previously reported as hypoxia-selective cytotoxins. In this paper we describe the synthesis and evaluation of a series of heterocyclic analogues, including pyrrole, imidazole, thiophene, and pyrazole examples, chosen to cover a range of one-electron reduction potentials (from -277 to -511 mV) and substitution patterns. All quaternary salt compounds were less toxic in vitro than mechlorethamine, and all were more toxic under hypoxic than aerobic conditions, although the differentials were highly variable within the series. The most promising analogue, imidazole 2, demonstrated DNA cross-linking selectively in hypoxic RIF-1 cells, and was active in vivo in combination with radiation or cisplatin. However, 2 also produced unpredictable toxicity in vivo, suggestive of nonspecific nitrogen mustard release, and this has restricted further development of these compounds as hypoxia-selective cytotoxins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585455     DOI: 10.1021/jm010202l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Hydrogen peroxide activated quinone methide precursors with enhanced DNA cross-linking capability and cytotoxicity towards cancer cells.

Authors:  Yibin Wang; Heli Fan; Kumudha Balakrishnan; Zechao Lin; Sheng Cao; Wenbing Chen; Yukai Fan; Quibria A Guthrie; Huabing Sun; Kelly A Teske; Varsha Gandhi; Leggy A Arnold; Xiaohua Peng
Journal:  Eur J Med Chem       Date:  2017-03-24       Impact factor: 6.514

2.  Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept Study.

Authors:  Victoria C Yan; Kristine L Yang; Elliot S Ballato; Sunada Khadka; Prakriti Shrestha; Kenisha Arthur; Dimitra K Georgiou; Mykia Washington; Theresa Tran; Anton H Poral; Cong-Dat Pham; Matthew J Yan; Florian L Muller
Journal:  ACS Med Chem Lett       Date:  2020-06-22       Impact factor: 4.345

3.  Tirapazamine plus cisplatin and irradiation in a mouse model: improved tumor control at the cost of increased toxicity.

Authors:  Markus Adam; Christine Bayer; Julia Henke; Anca Grosu; Michael Molls; Carsten Nieder
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-11       Impact factor: 4.553

Review 4.  Nitroaromatic Hypoxia-Activated Prodrugs for Cancer Therapy.

Authors:  William A Denny
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.